Trial intelligence / Profile preview

Ototopical antibiotic-steroid drops vs oral antibiotics vs watchful waiting for acute tympanostomy tube otorrhea in children

2008-005066-32Phase 4Completed

Sponsor
University Medical Center of Southern Nevada
Start
Oct 2008
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, randomised trial of hydrocortisone acetate + bacitracin + colistin and amoxicillin + clavulanate in otorrhea and tympanostomy tube otorrhea (TTO) (3 arms), sponsored by University Medical Center of Southern Nevada. Primary endpoint: Otoscopic signs of otorrhea at 2 weeks. Started Oct 2008; status: completed.

02

Drugs

hydrocortisone acetate + bacitracin + colistinamoxicillin + clavulanate
03

Conditions

otorrheatympanostomy tube otorrhea (TTO)

Beyond the preview

Go deeper on 2008-005066-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005066-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call